DE69634138D1 - HGF Mutant und dessen Verwendung als Antikrebsmittel - Google Patents

HGF Mutant und dessen Verwendung als Antikrebsmittel

Info

Publication number
DE69634138D1
DE69634138D1 DE69634138T DE69634138T DE69634138D1 DE 69634138 D1 DE69634138 D1 DE 69634138D1 DE 69634138 T DE69634138 T DE 69634138T DE 69634138 T DE69634138 T DE 69634138T DE 69634138 D1 DE69634138 D1 DE 69634138D1
Authority
DE
Germany
Prior art keywords
alpha
hgf
fragment
active ingredient
anticancer agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69634138T
Other languages
English (en)
Other versions
DE69634138T2 (de
Inventor
Toshikazu Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69634138D1 publication Critical patent/DE69634138D1/de
Publication of DE69634138T2 publication Critical patent/DE69634138T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69634138T 1995-10-24 1996-10-23 HGF Mutant und dessen Verwendung als Antikrebsmittel Expired - Lifetime DE69634138T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30072895A JP3832674B2 (ja) 1995-10-24 1995-10-24 抗癌剤
JP30072895 1995-10-24
PCT/JP1996/003105 WO1997016205A1 (fr) 1995-10-24 1996-10-23 Agent antitumoral

Publications (2)

Publication Number Publication Date
DE69634138D1 true DE69634138D1 (de) 2005-02-03
DE69634138T2 DE69634138T2 (de) 2006-02-09

Family

ID=17888391

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69634138T Expired - Lifetime DE69634138T2 (de) 1995-10-24 1996-10-23 HGF Mutant und dessen Verwendung als Antikrebsmittel

Country Status (7)

Country Link
EP (1) EP0890361B1 (de)
JP (1) JP3832674B2 (de)
AT (1) ATE285785T1 (de)
CA (1) CA2235805C (de)
DE (1) DE69634138T2 (de)
ES (1) ES2235200T3 (de)
WO (1) WO1997016205A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
WO2001044294A2 (en) * 1999-12-15 2001-06-21 Entremed, Inc. Compositions and methods for inhibiting endothelial cell proliferation
ES2295198T3 (es) 2000-08-28 2008-04-16 Damavand Wound Ab Los efectos sinergicos de hgf y tratamiento antibacteriano.
US20030118585A1 (en) 2001-10-17 2003-06-26 Agy Therapeutics Use of protein biomolecular targets in the treatment and visualization of brain tumors
AU2004298483A1 (en) * 2003-12-11 2005-06-30 Genentech, Inc. Methods and compositions for inhibiting c-met dimerization and activation
EP1957102B1 (de) * 2005-11-16 2012-01-18 Fariba Nayeri Verfahren zur hemmung von krebsbildung und/oder metastasen bei einer person durch endogene c-met-liganden und -hemmer
WO2009125831A1 (ja) * 2008-04-11 2009-10-15 有限会社スリーピー Ｎｋ４に対するモノクローナル抗体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566098B1 (en) * 1990-09-14 2003-05-20 The United States Of America As Represented By The Department Of Health And Human Services DNA encoding truncated hepatocyte growth factor variants
JP3030386B2 (ja) * 1991-05-15 2000-04-10 敏一 中村 抗ガン剤
CA2118012A1 (en) * 1992-05-18 1993-11-25 Paul J. Godowski Hepatocyte growth factor variants
EP0662130B1 (de) * 1992-09-18 1997-11-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Eine Methode zur Herstellung von Hepatozytwachstumsfaktor und eine Zelllinie

Also Published As

Publication number Publication date
CA2235805A1 (en) 1997-05-09
EP0890361B1 (de) 2004-12-29
WO1997016205A1 (fr) 1997-05-09
EP0890361A1 (de) 1999-01-13
JPH09110716A (ja) 1997-04-28
DE69634138T2 (de) 2006-02-09
ATE285785T1 (de) 2005-01-15
JP3832674B2 (ja) 2006-10-11
ES2235200T3 (es) 2005-07-01
EP0890361A4 (de) 2001-04-11
CA2235805C (en) 2008-10-28

Similar Documents

Publication Publication Date Title
DE69931930D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
CZ143795A3 (en) 7-halo and 7-beta, 8-betamethanotaxols, their anti-neoplastic use and pharmaceutical compositions containing thereof
IL107109A0 (en) Compounds for modifying drug resistance and pharmaceutical compositions containing the same
PL367682A1 (en) Dolastatin 10 derivatives
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
TR200200717T2 (tr) Terapötik kinazolin türevleri.
UA50719C2 (uk) Проліки для терапії пухлин і запальних захворювань
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
DE69430611D1 (de) Phosphonooxymethyl oder Methylthiomethylether von Taxanderivaten als Antitumormittel
MX9603052A (es) Analogos delta 12.13 iso-taxol uso antineoplastico y las composiciones farmaceuticas que los contienen.
ATE171170T1 (de) 7-äther-taxol ähnliche verbindungen antineoplastische verwendung und diese enthaltende pharmazeutische zusammenstellungen
DE60209721D1 (de) Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore
ME00056B (me) Kombinacija kombrestatina i anti-kancer agensa
DE69634138D1 (de) HGF Mutant und dessen Verwendung als Antikrebsmittel
IL149134A0 (en) Pharmaceutical compositions containing tofisopam
IS2387B (is) Æxliseyðandi efni
HUP0300848A2 (hu) Kamptotecint és egy pirimidinszármazékot tartalmazó készítmény rák kezelésére
EP1427418A4 (de) Piperazinon-verbindungen als antitumorale und krebsbekämpfende mittel und behandlungsverfahren
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
DE69312567T2 (de) 2-Formylpyridin-Thiosemicarbazonderivate, ihre Herstellung und ihre Verwendung als Antitumor Mittel
IL172538A0 (en) Depsipeptide compounds, pharmaceutical compositions containing the same and processes for the preparation thereof
BR9908796A (pt) Uso de compostos de macrolìdeo, método de tratamento e prevenção de ards, composição farmacêutica e composto macrolìdeo
MX9702671A (es) Derivados metalocenicos de diariletileno, metodos de preparacion y composiciones farmaceuticas que contienen estos derivados.
AP2002002453A0 (en) Chemosensitizer
PT1551850E (pt) 2 oxo-voruscharina e seus derivados

Legal Events

Date Code Title Description
8364 No opposition during term of opposition